爱尔眼科(300015) - 2015 Q2 - 季度业绩预告

Financial Performance - The company expects a net profit attributable to shareholders of approximately 194.52 million to 208.93 million CNY, representing a year-on-year increase of 35% to 45%[3] - The net profit for the same period last year was 144.09 million CNY[3] - The increase in performance is attributed to the growing demand in the ophthalmology market and the company's expanding scale and brand influence[5] - The company anticipates a negative impact of approximately 4 million CNY from non-recurring gains and losses on net profit during this reporting period[6] - The performance forecast has not been audited by a registered accountant[4] - The financial data presented is based on preliminary estimates by the company's finance department, with detailed figures to be disclosed in the 2015 semi-annual report[7]